Mechanisms of liver cell injury

Journal of Hepatology

Volumn 32, Issue SUPPL.1, 2000, Pages 39-47

  Kaplowitz, Neil ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Apoptosis; Caspases; Necrosis; Oxidative stress

Indexed keywords

CASPASE; NITRIC OXIDE; REACTIVE OXYGEN METABOLITE; ADENOSINE TRIPHOSPHATE; CELL SURFACE RECEPTOR; CERAMIDE; CYTOCHROME C; FAS ANTIGEN; HYDROLASE; INTERLEUKIN 10; INTERLEUKIN 6; PROTEIN BAD; PROTEIN BAX; PROTEIN BCL 2; PROTEIN BCL X; SCATTER FACTOR; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR;

ANIMAL; APOPTOSIS; CYTOLOGY; GASTROENTEROLOGY; HUMAN; LIVER; LIVER DISEASE; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW; CELL DEATH; CHOLESTASIS; DRUG INDUCED DISEASE; ENZYME ACTIVATION; HYPOXIA; LIVER CELL DAMAGE; LIVER ISCHEMIA; LIVER MITOCHONDRION; PRIORITY JOURNAL; PROTEIN DEGRADATION; REPERFUSION INJURY; SIGNAL TRANSDUCTION; VIRUS INFECTION;

ANIMALS; APOPTOSIS; CASPASES; GASTROENTEROLOGY; HUMANS; LIVER; LIVER DISEASES; NITRIC OXIDE; REACTIVE OXYGEN SPECIES;

EID: 0033649270     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0168-8278(00)80414-6     Document Type: Article

References (66)

1. Ashkenazi A, Dixit V. Death receptors: Signaling and modulation. Science 1998; 281: 1305-8.
2. Faubion WA, Guicciardi ME, Miyoshi H, et al. Toxic bile salts induce rodent hepatocyte apoptosis via direct activation of Fas. J Clin Invest 1999; 103: 137-45.
3. Faubion WA, Gores G. Death receptors in liver biology and pathology. Hepatology 1999; 29: 1-4.
4. Green DR. Apoptosis pathways: the roads to ruin. Cell 1998; 94: 695-8.
5. Bradham CA, Plumpe J, Manns MP, et al. Mechanisms of hepatic toxicity. I. TNF- induced liver injury. Am J Physiol 1998; 275: G387-92.
6. Lawson JA, Fisher MA, Simmons CA, et al. Parenchymal cell apoptosis as a signal for sinusoidal sequestration and transendothelial migration of neutrophils in murine models of endotoxin and Fas-antibody-induced liver injury. Hepatology 1998; 28: 761-7.
7. Thornberry NA, Lazebnik Y. Caspase: enemies within. Science 1998; 281: 1312-6.
8. Yang X, Stennicke HR, Wang B, et al. Granzyme B mimics apical caspase. J Biol Chem 1998; 273: 34278-83.
9. Wood DE, Newcomb EW Caspase-dependent activation of calpain during drug-induced apoptosis. J Biol Chem 1999; 274: 8309-15.
10. Kohli V, Madden JF, Bentley RC, et al. Calpain mediates ischemic injury of the liver through modulation of apoptosis and necrosis. Gastroenterology 1999; 116: 168-78.
11. Scaffidi C, Fulda S, Srinivasasn A, et al. Two CD95 (APO-1/Fas) signaling pathways. EMBO J 1998; 17: 1675-87.
12. Susin S, Lorenzo H, Zamzami N, et al. Molecular characterization of mitochondrial apoptosis-inducing factor. Nature 1999; 397: 441-6.
13. Lorenzo HK, Susin SA. Penninger J, Kroemer G. Apoptosis inducing factor (AIF): a phylogenetically old, caspase-independent effector of cell death. Cell Death Different 1999; 6: 516-24.
14. Vaux DL. Caspases and apoptosis - biology and terminology. Cell Death Different 1999; 6: 493-4.
15. Borner C, Monney L. Apoptosis without caspases: an inefficient molecular guillotine? Cell Death Different 1999; 6: 497-507.
16. Samali A, Zhivotovsky B, Jones D. Nagat S, Orrenius S. Apoptosis: cell death defined by caspase activation. Cell Death Different 1999; 6: 495-6.
17. Hirsch T, Marchetti P, Susin SA, et al. The apoptosis-necrosis paradox. Apoptosis proteases activated after mitochondrial permeability transition determine the mode of cell death. Oncogene 1997; 15: 1573-81.
18. Susin SA, Zamzami N, Kroemer G. Mitochondria as regulators of apoptosis: doubt no more. Biochim Biophys Acta 1998; 1336: 151-65.
19. Lemasters JJ. Mechanisms of hepatic toxicity v. necrapoptosis and the mitochondrial permeability transition: shared pathways to necrosis and apoptosis. Am J Physiol 1999: 276: G1-6.
20. Susin SA, Lorenzo HK, Zamzami N, et al. Mitochondrial release of caspase-2 and -9 during the apoptotic process. J Exp Med 1999; 189: 381-94.
21. Finucane DM, Bossy-Wetzel E, Waterhouse NJ, et al. Bax-induced caspase activation and apoptosis via cytochrome c release from mitochondria is inhibitable by Bcl-xL. J Biol Chem 1999; 274: 2225-33.
22. Adams JM, Cory S. The Bcl-2 protein family: arbiters of cell survival. Science 1998; 281: 1322-6.
23. Kroemer G. The proto-oncogene Bcl-2 and its role in regulating apoptosis. Nature Med 1997; 3: 614-20.
24. Reed JC, Jurgensmeier JM, Matsuyama S. Bcl-2 family proteins and mitochondria. Biochim Biophys Acta 1998; 1366: 127-37.
25. Desagher S, Osen-Sand A, Nichols A, Eskes R, Montessuit S, Lauper S, et al. Bid- induced comformational change of Bax is responsible for mitochondrial cytochrome c release during apoptosis. J Cell Biol 1999; 144: 891-901.
26. Krebs JF, Armstrong RC, Srinivasan A, Aja T, Wong AM, Aboy A, et al. Activation of membrane-associated procaspase-3 is regulated by Bcl-2. J Cell Biol 1999; 144: 915-26.
27. Schwandner R, Wiegmann K, Bernardo K, et al. TNF receptors death domain-associated proteins TRADD and FADD signal activation of acid sphingomyelinase. J Biol Chem 1998; 273: 5916-22.
28. Schütze S, Mackleidt T, Adam D, et al. Inhibition of receptor internalization by monodanyslcadaverine selectively blocks p55 tumor necrosis factors receptor death domaine signaling. J Biol Chem 1999; 274: 10203-12.
29. Ghafourifar P, Klein SD, Schucht O, et al. Ceramide induces cytochrome c release from isolated mitochondria. J Cell Biol 1999; 274: 6080-4.
30. Garcia-Ruiz C, Colell A, Mari M, et al. Direct effect of ceramide on the mitochondrial electron transport chain leads to generation of reactive oxygen species. J Biol Chem 1997; 272: 11369-77.
31. Ruvolo PP, Deng X, Ito T, Carr BK, May WS. Ceramide induces Bcl2 dephosphorylation via a mechanism involving mitochondrial PP2A. J Biol Chem 1999; 274: 20296-300.
32. Roy N, L.Deveraux Q, Takahashi R, et al. The c-IAP-1 and c-IAP-2 proteins are direct inhibitors of specific caspases. EMBO J 1997; 16: 6914-25.
33. Seol DW, Billiar TR. A caspase-9 variant missing the catalytic site is an endogenous inhibitor of apoptosis. J Biol Chem 1999; 274: 2072-6.
34. Wang CY, Mayo MW, Korneluk RG, et al. NF-κB antiapoptosis: induction of TRAF1 and TRAF2 and C-IAP1 and c-IAP2 to suppress caspase-8 activation. Science 1998; 281: 1680-3.
35. Chu ZL, McKinsey T, Liu L, et al. Suppression of tumor necrosis factor-induced cell death by inhibitor of apoptosis c-IAP2 is under NF-κB control. Proc Natl Acad Sci USA 1997; 94: 10057-62.
36. Li J, Billiar TR. Nitric oxide. IV. Determinants of nitric oxide protection and toxicity in liver. Am J Physiol 1999; 276: G1069-73.
37. Hampton MB, Orrenius S. Dual regulation of caspase activity by hydrogen peroxide: implications for apoptosis. FEBS Lett 1997; 414: 552-6.
38. Ruemmele FM, Dionne S, Levy E, Seidman EG. TNF-induced IEC cell apoptosis requires activation of ICE caspases whereas complete inhibition of the caspase cascade leads to necrotic cell death. Biochem Biophys Res Commun 1999; 260: 159-66.
39. Leist M, Single A, Castoldi AF, et al. Intracellular adenosine triphosphate (ATP) concentration: a switch in the decision between apoptosis and necrosis. J Exp Med 1997; 185: 1481-6.
40. Lee Y, Shacter E. Oxidative stress inhibits apoptosis in human lymphoma cells. J Biol Chem 1999; 274: 19792-8.
41. Jiang Y, Woronicz JD, Goeddel DV. Prevention of constitutive TNF receptor 1 signaling by silencer of death domains. Science 1999; 283: 543-6.
42. Kaplowitz N, Tsukamoto H. Oxidative stress and liver disease. Prog Liver Dis 1996; XIV: 131-59.
43. Cai J, Jones DP. Superoxide in apoptosis. J Biol Chem 1998; 273: 11401-4.
44. Vandendobbcrlsteen DJ, Nobel CSI, Schlegel J, et al. Rapid and specific efflux of reduced glutathione during apoptosis induced by anti-Fas/APO-1 antibody. J Biol Chem 1996; 271: 15420-7.
45. DeLeve LP, Wang XD, Huybrechts MM. Cellular target of cyclophosphamide toxicity in the murine liver - role of glutathione and site of metabolic activation. Hepatology 1996; 24: 830-7.
46. Wanner GA, Mica L, Wanner-Schmid E, Kolb SA, Hentze H, Trentz O et al. Inhibition of caspase activity prevents CD95-mediated hepatic microvascular perfusion failure and restores Kupffer cell clearance capacity. FASEB J 1999; 13: 1239-48.
47. Müschen M, Warskulat U, Douillard P, et al. Regulation of CD95 (APO-1/Fas) receptor and ligand expression by lipopolysaccharide and dexamethasone in parenchymal and nonparenchymal rat liver cells. Hepatology 1998; 27: 200-8.
48. Colell A, García-Ruiz C, Morales A, et al. Transport of reduced glutathione in hepatic mitochondria and mitoplasts from ethanol-treated rats: Effect of membrane physical properties and S-adenosyl-L-methionine. Hepatology 1997; 26: 699-708.
49. Colell A, García-Ruiz C, Miranda M, et al. Selective glutathione depletion of mitochondria by ethanol sensitizes hepatocytes to tumor necrosis factor. Gastroenterology 1998; 115: 1541-51.
50. Michael SL, Pumford NR, Mayeux PR, Niesman MR, Hinson JA. Pretreatment of mice with macrophage inactivators decreases acetaminophen hepatotoxicity and the formation of reactive oxygen and nitrogen species. Hepatology 1999; 30: 186-95.
51. Hiramatsu N, Hayashi N, Katayama K et al. Immunohistochemical detection of Fas antigen in liver tissue of patients with chronic hepatitis C. Hepatology 1994; 19: 1354-9.
52. Galle PR, Hofmann WJ, Walczak H, et al. Involvement of the CD95 (APO-1/Fas) receptor and ligand in liver damage. J Exp Med 1995; 182: 1223-30.
53. Benedetti A, Brunelli E, Risicato R, et al. Subcellular changes and apoptosis induced by ethanol in rat liver. J Hepatol 1988; 6: 137-43.
54. Goldin RD, Hunt NC, Clark J, et al. Apoptotic bodies in a murine model of alcoholic liver disease: reversibility of ethanol-induced changes. J Pathol 1993; 171: 73-6.
55. Baroni GS, Marucci L, Benedetti A, et al. Chronic ethanol feeding increases apoptosis and cell proliferation in rat liver. J Hepatol 1994; 20: 508-13.
56. Yacoub LK, Fogt F, Griniuviene B, et al. Apoptosis and Bcl-2 protein expression in experimental alcoholic liver disease in the rat. Alcohol Clin Exp Res 1995; 19: 854-9.
57. Nanji A. Apoptosis and alcoholic liver disease. Semin Liver Dis 1998; 18: 187-90.
58. Wu D, Cederbaum AI. Ethanol-induced apoptosis to stable HepG2 cell lines expressing human cytochrome P-4502E1. Alcohol Clin Exp Res 1999; 23: 67-76.
59. Strand S, Hofmann WJ, Grambihler A, et al. Hepatic failure and liver damage in acute Wilson's disease involve CD95 (APO-1/Fas) mediated apoptosis. Nature Med 1998; 4: 588-93.
60. Czaja MJ, Xu J, Alt E. Prevention of carbon-tetrachloride-induced rat liver injury by soluble tumor necrosis factor receptor. Gastroenterology 1995; 108: 1849-54.
61. Laskin DL, Gardner CR, Price VF, et al. Modulation of macrophage functioning abrogates the acute hepatotoxicity of acetaminophen. Hepatology 1995; 21: 1045-50.
62. Ray SD, Mumaw VR, Raje RR, et al. Protection of acetaminophen-induced hepatocellular apoptosis and necrosis by cholesteryl hemisuccinate pretreatment. J Pharmacol Exp Therap 1996; 279: 1470-83.
63. Feng F, Kaplowitz N. Colchicine protects mice from the lethal effect of agonistic anti-Fas antibody. J Clin Invest 2000; in press.
64. Botla R, Spivey J, Aguilar H, et al. Ursodeoxycholate (UDCA) inhibits the mitochondrial membrane permeability transition induced by glycochenodeoxycholate: a mechanism of UDCA cytoprotection. J Pharmacol Exp Ther 1995; 272: 930-8.
65. Rodrigues CMP, Fan G, Ma X, et al. A novel role for ursodeoxycholic acid in inhibiting apoptosis by modulating mitochondrial membrane perturbation. J Clin Invest 1998; 101: 2790-9.
66. Lemaire C, Andréau K, Souvannavong V et al. Inhibition of caspase induces a switch from apoptosis to necrosis. FEBS Lett 1998; 425: 266-70.